Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
WAT 
Waters Corporation (WAT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/31/2025: WAT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
22 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $373.98
1 Year Target Price $373.98
| 6 | Strong Buy |
| 1 | Buy |
| 15 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.94% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/31/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 17.28B USD | Price to earnings Ratio 26.32 | 1Y Target Price 373.98 |
Price to earnings Ratio 26.32 | 1Y Target Price 373.98 | ||
Volume (30-day avg) 22 | Beta 1.1 | 52 Weeks Range 279.62 - 423.56 | Updated Date 08/1/2025 |
52 Weeks Range 279.62 - 423.56 | Updated Date 08/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 11.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-04 | When Before Market | Estimate 2.95 | Actual - |
Profitability
Profit Margin 22.02% | Operating Margin (TTM) 22.93% |
Management Effectiveness
Return on Assets (TTM) 11.61% | Return on Equity (TTM) 40.82% |
Valuation
Trailing PE 26.32 | Forward PE 22.22 | Enterprise Value 18337251539 | Price to Sales(TTM) 5.79 |
Enterprise Value 18337251539 | Price to Sales(TTM) 5.79 | ||
Enterprise Value to Revenue 6.15 | Enterprise Value to EBITDA 17.4 | Shares Outstanding 59509100 | Shares Floating 59389476 |
Shares Outstanding 59509100 | Shares Floating 59389476 | ||
Percent Insiders 0.16 | Percent Institutions 98.22 |
Upturn AI SWOT
Waters Corporation
Company Overview
History and Background
Waters Corporation was founded in 1958 by James Waters. Initially focused on liquid chromatography, it evolved into a global leader in analytical instruments and software for the life sciences, pharmaceutical, and materials science industries. Significant milestones include the development of advanced chromatography techniques and mass spectrometry systems.
Core Business Areas
- Waters Division: Develops and manufactures high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), mass spectrometry (MS) systems, and related consumables and services for separations science.
- TA Instruments Division: Focuses on thermal analysis, rheology, and microcalorimetry instruments, used for material characterization and analysis.
Leadership and Structure
The leadership team consists of Udit Batra (President and CEO), Amol Chaubal (CFO), and other executives. Waters operates with a divisional structure, separating its Waters and TA Instruments businesses.
Top Products and Market Share
Key Offerings
- ACQUITY UPLC Systems: Ultra-high performance liquid chromatography systems. Market share is significant in HPLC, estimated at around 25%. Competitors include Agilent, Thermo Fisher Scientific, and Shimadzu. Significant revenue driver for Waters Division.
- TRIOS Software: Thermal Analysis software from TA Instruments, Used for thermal analysis, rheology, and microcalorimetry instruments
- Xevo Mass Spectrometry Systems: Mass spectrometry systems used in various applications. Market share estimated around 20% in mass spectrometry. Competitors include Agilent, Thermo Fisher Scientific, and Bruker.
Market Dynamics
Industry Overview
The analytical instrument industry is driven by growth in pharmaceuticals, biotech, environmental testing, and materials science. It's characterized by technological innovation, increasing regulatory requirements, and global expansion.
Positioning
Waters is a leader in chromatography and mass spectrometry. It competes on technology, service, and applications expertise. Its competitive advantage lies in its brand reputation and innovative product portfolio.
Total Addressable Market (TAM)
The total addressable market for analytical instruments is estimated to be over $70 billion. Waters is well-positioned to capture a significant portion of this TAM through its product offerings and global presence.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Innovative product portfolio
- Global presence
- Strong service network
- High customer loyalty
Weaknesses
- Dependence on pharmaceutical and biotech industries
- High product prices
- Limited diversification beyond analytical instruments
- Slower growth compared to some competitors
Opportunities
- Expanding into emerging markets
- Developing new applications for existing products
- Acquiring complementary businesses
- Increasing focus on software and data analytics
Threats
- Intense competition
- Economic downturns
- Technological disruptions
- Regulatory changes
- Fluctuations in currency exchange rates
Competitors and Market Share
Key Competitors
- AGIL
- TMO
- SHI.KL
Competitive Landscape
Waters competes with other analytical instrument companies based on technology, price, service, and applications expertise. Waters' competitive advantage lies in its brand reputation and innovative product portfolio.
Major Acquisitions
Andrew Alliance
- Year: 2019
- Acquisition Price (USD millions): 250
- Strategic Rationale: Expanded Waters' capabilities in laboratory automation.
Growth Trajectory and Initiatives
Historical Growth: Waters has experienced moderate growth over the past decade, driven by demand for its products in the pharmaceutical and life sciences industries.
Future Projections: Analysts project moderate revenue growth for Waters in the coming years, driven by new product launches and expansion into emerging markets.
Recent Initiatives: Recent initiatives include investments in new product development, acquisitions of complementary businesses, and expansion of its service offerings.
Summary
Waters Corporation is a leading analytical instrument company with a strong position in chromatography and mass spectrometry. It benefits from a strong brand and innovative products, but faces competition and dependence on certain industries. Waters has a good reputation. They need to focus on continued innovation and market diversification.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Waters Corporation
Exchange NYSE | Headquaters Milford, MA, United States | ||
IPO Launch date 1995-11-16 | President, CEO & Director Dr. Udit Batra Ph.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 7600 | Website https://www.waters.com |
Full time employees 7600 | Website https://www.waters.com | ||
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.